Early research (Phase 1)Study completedNCT00668512What this trial is testingIntratumoral Injection Of Alpha-Gal GlycosphingolipidsWho this might be right forMetastatic Melanoma University of Massachusetts, Worcester 12
Testing effectiveness (Phase 2)Study completedNCT00295958What this trial is testingLMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By SurgeryWho this might be right forMelanoma (Skin)Non-melanomatous Skin Cancer National Institutes of Health Clinical Center (CC) 26
Not applicableStudy completedNCT04698161What this trial is testingEstablishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic DiseasesWho this might be right forNon Small Cell Lung CancerMetastatic Melanoma Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 50
Testing effectiveness (Phase 2)Ended earlyNCT05926960What this trial is testingA Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced MelanomaWho this might be right forMelanoma Pfizer 38
Early research (Phase 1)Study completedNCT06469138What this trial is testingInvestigate 14C-bemcentinib in Healthy Male SubjectsWho this might be right forNon-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more BerGenBio ASA 6
Not applicableLooking for participantsNCT06586593What this trial is testingNeoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)Who this might be right forMelanoma Metastatic Centre Hospitalier Universitaire de Besancon 77
Testing effectiveness (Phase 2)Ended earlyNCT01586195What this trial is testingStudy Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600EWho this might be right forMalignant Melanoma Genentech, Inc. 31
Not applicableStudy completedNCT01415167What this trial is testingPROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in MalignancyWho this might be right forMetastatic Renal Cell CarcinomaMetastatic Melanoma Prometheus Laboratories 1,690
Early research (Phase 1)Study completedNCT00471471What this trial is testingVaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forIntraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin) Ahmad Tarhini 22
Not applicableStudy completedNCT02990611What this trial is testingObservational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab TherapyWho this might be right forMelanoma Bristol-Myers Squibb 1,087
Post-approval studies (Phase 4)Ended earlyNCT03673332What this trial is testingElderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPiesWho this might be right forAdvanced or Metastatic MelanomaAdvanced or Metastatic NSCLC Institut Paoli-Calmettes 40
Testing effectiveness (Phase 2)Study completedNCT00084656What this trial is testingMonoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) Bristol-Myers Squibb 77
Not applicableLooking for participantsNCT07148245What this trial is testingSymptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous MelanomaWho this might be right forCutaneous MelanomaCutaneous Melanoma, Stage IIICutaneous Melanoma by AJCC V7 Stage+1 more University of California, San Francisco 300
Testing effectiveness (Phase 2)Study completedNCT00669019What this trial is testingSaracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT01005472What this trial is testingTemozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaWho this might be right forMetastatic Melanoma Jonsson Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00482911What this trial is testingLenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaWho this might be right forIntraocular MelanomaMalignant Conjunctival Neoplasm National Institutes of Health Clinical Center (CC) 12
Testing effectiveness (Phase 2)Study completedNCT00314106What this trial is testingChemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic MelanomaWho this might be right forMetastatic Melanoma National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Ended earlyNCT01864538What this trial is testingBiomarker - Enriched Study of TH-302 in Subjects With Advanced MelanomaWho this might be right forMetastatic Melanoma ImmunoGenesis 11
Early research (Phase 1)Study completedNCT01469455What this trial is testingDNA Repair Inhibitor & Irradiation on MelanomaWho this might be right forLocal Metastatic Melanoma DNA Therapeutics 27
Early research (Phase 1)Study completedNCT00004148What this trial is testingVaccine Therapy in Treating Patients With Unresectable Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI) 12